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The respiratory system is majorly susceptible for infectious and non-infectious complications associated with human immunodeficiency virus (HIV) [1-4]. 
Respiratory illnesses of both acute and chronic nature are 
the most common presenting complaints and causes of 
morbidity among HIV-infected children [4-7]. In a study 
in Kenya [6], the major reasons for hospital admission in 
children with HIV/AIDS were malnutrition (40.8%) and 
pulmonary tuberculosis (PTB) (20.9%), while in another 
study in Zambia [7], upper respiratory tract infection (URTI) 
was a major cause of morbidity among HIV-infected children 
on antiretroviral (ARV) therapy with an incidence rate of 
100.6/100 children/years. HIV associated lung function 
decline is also well documented [8].
Chronic lung diseases in children with HIV include 
obliterative bronchiolitis, bronchiectasis, recurrent/persistent 
pneumonia of varied etiology, lymphocytic interstitial 
pneumonia (LIP), lung malignancies, pulmonary hypertension, 
interstitial pneumonitis, and immune reconstitution 
inflammatory syndrome among others [6-10]. These diagnoses 
sometimes require both a high index of suspicion and expertise 
to detect, and in resource-limited countries, there is more 
dependence on clinical features to make the diagnosis. There 
is inadequate data within the sub-region on lung pathologies 
affecting HIV-infected children and adolescents. This study 
thus assesses the prevalence and risk factors for respiratory 
disease among HIV-infected children attending our specialist 
clinic. This will highlight the burden of respiratory illness 
among HIV-infected children and possibly highlight the need 
for regular respiratory reviews and research for improved 
health outcomes in children with HIV.
ABSTRACT
Introduction: The lung is a major target for infectious and non-infectious complications of human immunodeficiency 
virus (HIV) infection. Objective: This study sought to assess the prevalence and pattern of respiratory diseases among 
HIV-infected children attending our pediatric HIV specialist clinic. Methods: A 10-year retrospective review of data 
on HIV-infected children seen at the Paediatric HIV clinic of the University of Nigeria Teaching Hospital, Ituku/Ozalla, 
Enugu. HIV diagnosis was made by HIV-DNA polymerase chain reaction testing and antibody testing depending on the age 
of the child. Diagnosis of pneumonia was made using the WHO pneumonia clinical algorithm while pulmonary tuberculosis 
(PTB) was diagnosed using clinical and radiological criteria. Data analyses were done with Statistical Package for the Social 
Sciences version 19 (Chicago, IL). Results: A total of 555 HIV-infected children were analyzed. There were 277 males 
(49.9%) with male to female ratio of 0.9–1. The cough was the most common complaint in 51.9% of the children. There were 
327 respiratory cases observed in 181 of 555 (34.7%) of the children. Using clinical symptoms, 65 of 327 (9.9%) of study 
participants had upper airway-related diseases with otitis media being most predominant (27/65; 41.5%); pneumonia was 
reported in 146 of 327 (45%) and PTB in 115 of 327 (35%). Total 124 of 181 children (72.5%) with respiratory infections 
compared to 18 of 287 (6.3%) without infections had an abnormal chest X-ray (CXR) (p<0.001). Identified risk factors for 
developing respiratory disease were low socio-economic status, being on second-line highly active antiretroviral therapy and 
having an abnormal CXR finding. Conclusions: Pneumonia and PTB are common in children with HIV. Chronic radiological 
change is more common among HIV-infected children with clinical features of respiratory pathology. The need for close lung 
function monitoring in children with HIV is recommended for early detection of morbidity associated with these infections.
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MATERIALS AND METHODS
Pediatric HIV clinic is a referral clinic located at the University 
of Nigeria Teaching Hospital (UNTH) Enugu, Southeast Nigeria. 
It was established in March 2004. The clinic attends to patient’s 
twice-weekly providing care and treatment for HIV-infected 
children, which includes nutritional check, tuberculosis (TB) 
screening, and laboratory services where blood parameters are 
monitored. The clinic receives referrals from health facilities 
within and outside Enugu metropolis and parts of the Southeast 
of Nigeria and attends to an average of 20 patients/week. Ethical 
approval was obtained from the Health Research and Ethics 
Committee of UNTH Enugu.
This was a retrospective study. The electronic medical records 
at enrolment of HIV-infected children seen between December 
2004 and November 2015 were extracted and critically reviewed. 
Inclusion criteria enlisted participants whose HIV results 
were clearly documented as positive in the folder, for whom 
standard methods of HIV testing were used. Participants with 
inconclusive HIV result, those with only HIV exposure but not 
confirmed disease and those with missing data on respiratory 
and demographic variables were excluded from the study. HIV 
diagnosis was based on positive HIV DNA polymerase chain 
reaction (PCR) testing for children younger than 18 months and 
antibody testing for children ≥18 months.
Diagnosis of pneumonia was made using the WHO pneumonia 
clinical algorithm [9,10]. Furthermore, chest X-ray (CXR) was 
used to confirm “pneumonic” changes such as bronchovascular 
markings or reticular densities, parenchymal consolidation, 
nodular densities, hyperinflation, fibrosis, cavities, and interstitial. 
Diagnosis of PTB was done using clinical and radiological criteria 
(fever, cough of >1-month duration, weight loss, history of contact 
with an adult with chronic cough, night sweats, positive smear/
Gene Xpert test of sputum or gastric aspirate where available). 
Radiological signs that were used as “suggestive of TB” were 
miliary nodules, airway narrowing, and tracheal deviation to 
the left, presence of hilar, paratracheal, subcarinal, or another 
lymphadenopathy, evidence of calcification, cavitation, pleural 
effusion, or thickening.
Using the case notes, these were analyzed with the clinical 
evidence by the researchers and the CXR interpretation was done 
by an independent consultant radiologist who was blinded to case 
note of patient. Socio-economic status (SES) was determined by 
modified validated methods described by Ogunlesi et al. Using 
the parenteral level of education and type of vocation of parents 
and these were further categorized into lower Class 3 (socio-
economic class [SEC] 4 and 5), middle Class 2 (SEC 2 and 3), 
and upper Class 1 (SEC 1) [11].
Risk factors for the presence of respiratory pathologies that 
were also sought for included age, gender, SES, and markers of 
disease severity such as the presence of digital clubbing, HIV 
stage, and highly active ARV therapy (HAART) status.
Retrieved data that were available for the various parameters were 
analyzed using the Statistical Package for the Social Sciences 
version 19.0 (Chicago IL). Individual variables were analyzed in 
isolation using univariate analysis. Student t-test and Analysis of 
Variance (ANOVA) were used to compare means of continuous 
variables while the Chi-square test was used to test the significant 
association of categorical variables. Regression analyses of 
risk factors for respiratory disease were also done. p<0.05 was 
regarded as statistically significant and 95% confidence interval 
was reported where indicated.
RESULTS
A total of 555 HIV-infected children were included in the 
data analysis with a mean age of 9.9±4.6 years (range 
2 months–22 years). There were 277 (49.9%) males with a male 
to female ratio of 0.9–1. Of all the study participants, 341 (61.4%) 
were from the lower social class, as shown in Table 1. Mother-to-
child transmission of HIV accounted for 481 (92.5%) of cases. 
The mean age at HIV diagnosis was 5.3±3.9 years. The mean CD4 
count was 681.52 (609.626) and RNA viral load of 394,043.36 
(log 5.6). There were 217 (39%) and 206 (37%) children who 
were at HIV Stages II and III, respectively. Sixty-one children 
had failed first-line ARVs medications and were on the second 
line (Table 1).
There were 327 respiratory related disease cases diagnosed in 
all study participants and occurred either alone or in combination 
with other respiratory diagnosis (Fig. 1).
Number Key to Respiratory Diseases
1=Otitis media 8.2%; 2=Upper airway obstruction (adenoidal 
hypertrophy, enlarged TB lymph node) 1.5%; 3=Parotitis 2.8%; 
4=Sinusitis 0.3%; 5=Other URTI 6.7%; 6=PTB 35.2%; 
7=Bronchopneumonia/lobar pneumonia 44.7%; 8=Pneumocystis 
Carinii Pneumonia (PCP) pneumonia 0.3%; 9=LIP 
pneumonia 0.3%
Table 1: Basic profile of the study participants with HIV





Upper class 24 (4.8)
Middle class 138 (27.4)







First line 346 (71.2)
Second line 61 (12.6)
Yet to commence HAART 79 (16.3)
HAART: Highly active antiretroviral therapy, HIV: Human immunodeficiency virus
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Cough as a symptom was the most common respiratory 
complaint and occurred in 271 of 555 (48.8%) of participants. 
Using clinical symptom analyses, 65 of 327 (19.9%) of all cases 
were upper airway-related diseases and otitis media were the 
most predominant (27/65; 41.5%), while pneumonia cases were 
146 of 327 (45%) and PTB reported in 115 of 327 (35%), both 
representing the predominant lower airway diseases. None of the 
children was previously hospitalized for PTB as at the time of 
recruitment. Only one child had digital clubbing. All children 
were fully immunized for age and as most were above 6 years, 
breastfeeding data were not included in analyses.
The mean age at HIV diagnosis among children with 
respiratory-related complaints was 4.9±3.3 years compared 
to 5.4±4.1 years among those without respiratory pathologies 
(p=0.14). Out of 277 males, 110 (39.7%) compared to 84 of 
278 females (30.2%) with HIV, had associated respiratory 
pathology (p=0.019), as depicted in Table 2.
Chest radiographs were requested in 458 children who required 
further evaluation of their respiratory symptoms. One hundred 
and forty-two (32%) of these children whose chest radiographs 
were studied, had an abnormal CXR, suggestive of possible 
bronchopneumonia, lobar pneumonia, PCP pneumonia, LIP, TB, 
and bronchiectasis. Finding an abnormality on CXR was positively 
associated with the presence of respiratory clinical symptoms. Of 
those who had clinical symptoms related to the respiratory system, 
124 of 171 (72.5%) had abnormal CXR, while among the 287 of 
555 who did not have respiratory-related symptoms only 18 of 
287 (6.3%) had any CXR abnormalities (p<0.001).
After adjusting for confounding variables, the SES (p=0.04), 
children on second-line HAART (p=0.03), and those with 
abnormal CXR (p=0.02) remained significant risk factors for 
respiratory infection in children with HIV (Table 3).
DISCUSSION
In consonance with previously conducted studies, it was observed 
that otitis media were the most prevalent upper respiratory 
pathology while cough was the most commonly reported 
symptom. Mehta et al. [12], in India, reported that 96% of their 
study participants presented with cough. URTI have in some 
reports occurred as frequently irrespective of HIV status [13]; 
however, the high incidence reported among children with 
HIV may be related to their immune deficiency status with a 
predisposition for organs such as the lungs. The incidence was 
as high as 33% in a study by Wallace et al. [14], who also noted 
chronic sinusitis to be common.
In another cohort study among adults with HIV, self-
reported acute sinusitis, acute bronchitis, pulmonary Kaposi 
sarcoma, asthma, and chronic obstructive pulmonary disease 
were documented [15]. High incidence of pneumonia and TB 
in HIV-infected individuals is reported as observed also in our 
series. Similar to our study, Mehta et al. [12] also reported that 
PTB was the most common respiratory infection in 72% of their 
study group far and above bacterial pneumonia reported in 22% 
of their study population. The high prevalence of pneumonia and 
TB as respiratory infections in people with HIV reinforces the 
immune dysfunction, especially for PTB when HIV has caused 
CD4 depletion when the two diseases coexist.
When making a diagnosis of TB in children, the use of 
clinical and radiologic criteria remains pertinent especially in 
resource-poor countries where there is limited access to advanced 
techniques for TB diagnosis in children such as sputum gene 
Xpert. This is more so when the “gold standard,” which is sputum 
culture may take as long as 6 weeks before obtaining results.
Furthermore, the diagnosis of TB in children infected with HIV 
is even more difficult [8], as the clinical and radiographic features 
are shared with other opportunistic diseases that occur in HIV [14]. 
This may have possibly contributed to the high prevalence in our 
study and that in India [12]. Controversies abound on inter and 
intra-observer discordance in CXR interpretation [16,17]. It is thus 
important to be cautious and not place more emphasis than required 
Table 2: Prevalence of respiratory illnesses among gender and SES
Characteristics Respiratory diseases p value
Yes (%) No (%)
Gender
Male 110 (39.7) 167 (60.3) 0.019
Female 84 (30.2) 194 (69.8)
SES
Upper class 5 (2.9) 19 (5.8) 0.212
Middle class 44 (25.3) 94 (28.6)
Lower class 125 (71.8) 216 (65.6)
SES: Socio-economic class
Table 3: Risk factors for respiratory disease in children with HIV
Possible risk factors Wald df p value
Gender 0.165 1 0.685
Age at HIV diagnosis 0.366 1 0.545
Duration of HAART treatment 0.525 5 0.991
Socioeconomic status 11.430 5 0.043
Vertical transmission 4.620 3 0.202
On first-line HAART 1.667 2 0.435
On second-line HAART 4.576 1 0.032
Abnormality in chest X-ray 7.342 2 0.025
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Figure 1: Pattern of respiratory infections in children with human 
immunodeficiency virus
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on CXR findings, but rather combine clinical, radiological, and 
other diagnostic tools where available.
However, in areas where TB is endemic, there should still be 
a call to action to make available the current and more reliable 
diagnostic tools and for proper contact tracing to be done for 
children in households with adults who have open TB. This 
would reduce transmission and eventually impact on high TB 
prevalence. Social status had a significant effect on the respiratory 
outcome. This emphasizes the need for proper education about 
TB and other respiratory illness at the grassroots, where poverty, 
ignorance, and disease will affect the outcome in children with 
HIV whose parents belong to the low social class.
A normal CD4+ count is from 500 to 1400 cells/mm3. This 
is affected by non-initiation or non-adherence to ARV therapy. 
With counts below 200 cells/mm3, susceptibility to opportunistic 
infections is made worse [13-15,18,19]. Our patients had a mean 
count above 600 cells/mm3. It is, however, important to note that 
when HIV is not diagnosed early, the patients are predisposed to 
several chest infections even at relatively high CD4+ counts [19] 
and if not managed properly, could be prone to chronic lung 
infections, poor lung function, [18] with the worse outcome 
due to advanced immunosuppression. In our study population, 
cases were diagnosed at about 5 years, though not yet immune 
suppressed.
The early initiation of ARV therapy, when CD4+ count is 
still expectedly high, is known to have a modulating effect on 
respiratory outcome in children with HIV [19]. In a study by 
Kitahata et al. [19], initiation of HAART before the CD4+ count 
reached below certain thresholds, significantly improved survival, 
when compared with those whose therapy had been deferred for 
one reason or another. Children who commenced second-line 
HAART may have thus been more likely to have been diagnosed 
late, among other possible reasons and thus explaining why it is a 
risk factor, as seen in our study.
Although CXR and its interpretation may be controversial in 
the diagnosis of respiratory infection, it is still a veritable screening 
tool and a good adjunct to clinical examination in detecting 
respiratory pathology even though not usually recommended in 
straight forward Community-Acquired Pneumonia [10,16,20]. 
Radiological findings in HIV infection may, however, be atypical 
and possibly difficult to distinguish between various respiratory 
diagnoses. However, when combined with other clinical 
parameters, it is still a very sensitive screening tool especially 
in resource-poor settings where access to the chest ultrasound, 
sputum induction techniques, and spirometry may be lacking.
In our study, abnormalities detected on CXR gave credence 
to clinical diagnoses earlier made such as pneumonia, TB, and 
bronchiectasis. Our study further supported the need for an 
initial request for CXR in HIV infected children with respiratory 
complaints as there was a significant finding of respiratory 
disease whenever abnormality on CXR was detected. Given 
the burden of respiratory disease in this population, having a 
sensitive and objective measure of lung function would be helpful 
for early detection of disease and longitudinal follow-up to 
optimize management and improve respiratory health outcomes. 
When following up children with HIV, serial measurement of 
lung function is thus imperative. Other chronic lung diseases like 
bronchiectasis were not prevalent in this study. It is possible that 
they were present but missed as information from spirometry and 
computed tomography (CT) scan would have been invaluable to 
support these diagnoses.
The present study had some limitations from our retrospective 
analyses. Core reliance on the clinical/X-ray diagnosis of 
pneumonia and TB may have led to over-diagnosis of these 
diseases. Bronchoalveolar lavage and sputum culture/PCR 
were not done; thus, the specific spectrum of microbiological 
organisms was not available as this would have been informative 
on the organism prevalent in HIV respiratory diseases in this 
region. CT scan of the chest was not done due to the cost, and 
thus, the prevalence of diseases like bronchiectasis may be 
wrongly misrepresented. The retrospective nature of the data used 
also limits inferences made from the study.
CONCLUSIONS
There was a significant finding of respiratory diseases among HIV-
infected children; with pneumonia and TB ranking the highest. 
Low SES, being on second-line HAART and having abnormal 
CXR are significant risk factors for respiratory infection among 
children with HIV. The need for full respiratory review, including 
lung function testing in children with HIV in the sub-region is 
recommended.
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